Biblio
Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins. Biochem Anal Biochem. 2012;Suppl 6(1).
. Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy. Oncotarget. 2015.
Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders. Hematology. 2015.
. . .